TMO FY 2008 Earnings Report — Thermo Fisher Scientific Inc. Revenue & Financial Results | Market Cap Arena

Thermo Fisher Scientific Inc.TMO

FY 2008 Earnings

Reported February 27, 2009

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2008	Prior Q	FY 2007	QoQ Change	YoY Change
Revenue	$10.5B	—	$9.7B	—	7.7%
Op. Income	$1.3B	—	$1.1B	—	18.8%
Gross Margin	40.4%	—	40.0%	—	0.5pp
Net Margin	9.5%	—	7.8%	—	1.7pp
EPS (Diluted)	$2.25	—	$1.72	—	30.8%
Free Cash Flow	$1.2B	—	$1.3B	—	-11.6%

Revenue Flow

Item	Amount
REVENUE	$10.5B
Cost of Revenue	$6.3B
GROSS PROFIT	$4.2B
R&D Expenses	$249M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$2.7B
Other Expenses	$35M
Operating Expenses	$3.0B
Cost & Expenses	$9.2B
OPERATING INCOME	$1.3B
Interest Income	$52M
Interest Expense	$130M
Other Income/Expenses	-$117M
INCOME BEFORE TAX	$1.1B
Income Tax Expense	$161M
Net Income from Continuing Ops	$989M
Net Income from Discontinued Ops	$0
Other Adjustments	$6M
NET INCOME	$994M
Net Income Deductions	$13M
BOTTOM LINE NET INCOME	$981M
D&A	$793M
EBIT	$1.3B
EBITDA	$2.1B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$10.5B
Cost of Revenue	$6.3B
GROSS PROFIT	$4.2B
R&D Expenses	$249M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$2.7B
Other Expenses	$35M
Operating Expenses	$3.0B
Cost & Expenses	$9.2B
OPERATING INCOME	$1.3B
Interest Income	$52M
Interest Expense	$130M
Other Income/Expenses	-$117M
INCOME BEFORE TAX	$1.1B
Income Tax Expense	$161M
Net Income from Continuing Ops	$989M
Net Income from Discontinued Ops	$0
Other Adjustments	$6M
NET INCOME	$994M
Net Income Deductions	$13M
BOTTOM LINE NET INCOME	$981M
D&A	$793M
EBIT	$1.3B
EBITDA	$2.1B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$989M
Depreciation & Amortization	$793M
Stock-Based Compensation	$57M
Deferred Income Tax	-$123M
Other Non-Cash Items	$23M
Change in Working Capital	-$318M
OPERATING CASH FLOW	$1.4B
Capital Expenditure	-$264M
Acquisitions (Net)	-$198M
Purchases of Investments	-$100.0K
Sales/Maturities of Investments	$600.0K
Other Investing Activities	$12M
NET CASH FROM INVESTING	-$450M
Net Debt Issuance	-$152M
Common Stock Repurchased	-$187M
Common Dividends Paid	$0
Other Financing Activities	$25M
NET CASH FROM FINANCING	-$228M
FREE CASH FLOW	$1.2B
Net Change in Cash	$655M

Balance Sheet

Item	Amount
Cash & Equivalents	$1.3B
Short-Term Investments	$8M
Net Receivables	$1.5B
Inventory	$1.2B
Other Current Assets	$408M
TOTAL CURRENT ASSETS	$4.3B
PP&E (Net)	$1.3B
Goodwill	$8.7B
Intangible Assets	$6.4B
Long-Term Investments	$10M
Tax Assets	$0
Other Non-Current Assets	$357M
TOTAL NON-CURRENT ASSETS	$16.7B
TOTAL ASSETS	$21.1B
Account Payables	$540M
Short-Term Debt	$15M
Deferred Revenue	$135M
Other Current Liabilities	$522M
TOTAL CURRENT LIABILITIES	$1.5B
Long-Term Debt	$2.0B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2.0B
Other Non-Current Liabilities	$602M
TOTAL NON-CURRENT LIABILITIES	$4.6B
TOTAL LIABILITIES	$6.2B
Common Stock	$422M
Additional Paid-In Capital	$11.3B
Retained Earnings	$3.5B
Treasury Stock	-$151M
Accum. Other Comp. Income	-$146M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$14.9B
Minority Interest	$0
TOTAL EQUITY	$14.9B
TOTAL LIABILITIES & EQUITY	$21.1B
Total Debt	$2.1B
Net Debt	$778M